#development

Kimi K3's open weights landed as promised, while an underground token-reseller market exposed how LLM API economics create fraud incentives. In pharma, argenx paid $2.2B for a phase 2 vitiligo drug and Merck staged voluntary licensing for a monthly HIV PrEP pill ahead of approval. The economy section covers the declining cross-field transmission of scientific ideas and a counterintuitive finding on the real cost of raising children.

Anthropic's Claude Sonnet 5 shipped on June 30 and Fable 5 returned globally on July 1 after the Department of Commerce lifted export controls that had restricted access for 19 days. Cloudflare declared a second Content Independence Day, launching a Monetization Gateway that lets site owners charge AI agents for any resource via stablecoin settlement over the x402 protocol, and released new granular controls to distinguish search bots from training bots. The FDA granted a historic clearance to an LLM-based diabetes management app, prompting debate about whether the model is an interface or a clinical decision-maker. Biotech stocks have now rallied for 15 consecutive months. The U.S. Department of Transportation proposed the first update to supersonic flight rules since the 1970s, opening the door to civilian supersonic travel.